Suvorexant: Perbedaan antara revisi
Konten dihapus Konten ditambahkan
WanaraLima (bicara | kontrib) Dibuat dengan menerjemahkan halaman "User:Mr. Ibrahem/Suvorexant" |
WanaraLima (bicara | kontrib) Artikel baru tentang topik farmasi yang masih memerlukan tambahan dan pengembangan |
||
Baris 11:
<!-- Chemical and physical data -->|C=23|Cl=1|H=23|N=6|O=2|smiles=C[C@@H]1CCN(CCN1C(=O)C2=C(C=CC(=C2)C)N3N=CC=N3)C4=NC5=C(O4)C=CC(=C5)Cl|StdInChI=1S/C23H23ClN6O2/c1-15-3-5-20(30-25-8-9-26-30)18(13-15)22(31)29-12-11-28(10-7-16(29)2)23-27-19-14-17(24)4-6-21(19)32-23/h3-6,8-9,13-14,16H,7,10-12H2,1-2H3/t16-/m1/s1|StdInChI_Ref={{stdinchicite|changed|chemspider}}|StdInChIKey=JYTNQNCOQXFQPK-MRXNPFEDSA-N|StdInChIKey_Ref={{stdinchicite|changed|chemspider}}}}
'''Suvorexant''' adalah [[obat]] yang digunakan untuk mengatasi [[insomnia]], juga untuk mengatasi kondisi sulit tidur dan kondisi tetap tertidur. <ref name="AHFS2021">{{Cite web|title=Suvorexant Monograph for Professionals |url=https://www.drugs.com/monograph/suvorexant.html |website=Drugs.com |language=en |archive-date=7 March 2016 |archive-url=https://web.archive.org/web/20160307083716/http://www.drugs.com/monograph/suvorexant.html |url-status=live |access-date=15 October 2021}}</ref> Penggunaan obat ini mungkin efektif setidaknya selama satu tahun. <ref name="AHFS2021">{{cite web |title=Suvorexant Monograph for Professionals |url=https://www.drugs.com/monograph/suvorexant.html |website=Drugs.com |accessdate=15 October 2021 |language=en |archive-date=7 March 2016 |archive-url=https://web.archive.org/web/20160307083716/http://www.drugs.com/monograph/suvorexant.html |url-status=live }}</ref> Aturan minum obat ini melalui oral, dan diminum setengah jam sebelum tidur. <ref name="AHFS2021">{{cite web |title=Suvorexant Monograph for Professionals |url=https://www.drugs.com/monograph/suvorexant.html |website=Drugs.com |accessdate=15 October 2021 |language=en |archive-date=7 March 2016 |archive-url=https://web.archive.org/web/20160307083716/http://www.drugs.com/monograph/suvorexant.html |url-status=live }}</ref>
Efek samping yang umum terjadi muncul rasa kantuk, sakit kepala, batuk, bermimpi, dan mulut kering. <ref name="AHFS2021">{{Cite web|title=Suvorexant Monograph for Professionals |url=https://www.drugs.com/monograph/suvorexant.html |website=Drugs.com |language=en |archive-date=7 March 2016 |archive-url=https://web.archive.org/web/20160307083716/http://www.drugs.com/monograph/suvorexant.html |url-status=live |access-date=15 October 2021}}<cite class="citation web cs1" data-ve-ignore="true">[https://www.drugs.com/monograph/suvorexant.html "Suvorexant Monograph for Professionals"]. ''Drugs.com''. [https://web.archive.org/web/20160307083716/http://www.drugs.com/monograph/suvorexant.html Archived] from the original on 7 March 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">15 October</span> 2021</span>.</cite></ref> Efek samping lainnya yang perlu diperhatikan secara serius yakni: [[kelumpuhan tidur]], muncul rasa ingin [[bunuh diri]], rasa cemas, dan menurunnya kemampuan mengemudi. <ref name="AHFS2021">{{cite web |title=Suvorexant Monograph for Professionals |url=https://www.drugs.com/monograph/suvorexant.html |website=Drugs.com |accessdate=15 October 2021 |language=en |archive-date=7 March 2016 |archive-url=https://web.archive.org/web/20160307083716/http://www.drugs.com/monograph/suvorexant.html |url-status=live }}</ref> Penggunaan pada ibu hamil dan menyusui masih belum diketahui secara jelas. <ref>{{Cite web|title=Suvorexant (Belsomra) Use During Pregnancy|url=https://www.drugs.com/pregnancy/suvorexant.html|website=Drugs.com|language=en|archive-url=https://web.archive.org/web/20210124004709/https://www.drugs.com/pregnancy/suvorexant.html|archive-date=24 January 2021|access-date=15 October 2021|url-status=live}}</ref> Obat ini merupakan [[antagonis reseptor]] orexin ganda (DORA). <ref name="AHFS2021">{{cite web |title=Suvorexant Monograph for Professionals |url=https://www.drugs.com/monograph/suvorexant.html |website=Drugs.com |accessdate=15 October 2021 |language=en |archive-date=7 March 2016 |archive-url=https://web.archive.org/web/20160307083716/http://www.drugs.com/monograph/suvorexant.html |url-status=live }}</ref>
| |||